Jane Street Group LLC Sells 98,683 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Jane Street Group LLC lowered its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 33.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 194,685 shares of the company's stock after selling 98,683 shares during the quarter. Jane Street Group LLC owned about 0.11% of Option Care Health worth $6,094,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in OPCH. Wellington Management Group LLP increased its stake in Option Care Health by 15.5% during the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company's stock worth $310,650,000 after purchasing an additional 1,328,326 shares in the last quarter. Wolverine Trading LLC bought a new stake in shares of Option Care Health during the third quarter worth $222,000. State Street Corp raised its holdings in shares of Option Care Health by 1.4% during the third quarter. State Street Corp now owns 6,257,172 shares of the company's stock worth $195,849,000 after acquiring an additional 83,395 shares during the period. Quarry LP lifted its position in Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after acquiring an additional 2,628 shares in the last quarter. Finally, Point72 DIFC Ltd acquired a new position in Option Care Health in the 3rd quarter worth $652,000. 98.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on OPCH. Barrington Research reduced their price target on Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a research report on Thursday, October 31st. Jefferies Financial Group cut shares of Option Care Health from a "buy" rating to a "hold" rating and reduced their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and cut their price target for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. UBS Group started coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a "neutral" rating and a $26.00 price objective for the company. Finally, Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $30.14.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH traded down $0.03 during midday trading on Monday, reaching $23.46. 1,781,829 shares of the company traded hands, compared to its average volume of 1,564,000. The firm's fifty day moving average price is $25.30 and its two-hundred day moving average price is $28.42. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $3.99 billion, a price-to-earnings ratio of 19.71, a price-to-earnings-growth ratio of 2.45 and a beta of 1.33. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the purchase, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.64% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.